Latest Posts
About This Stock
More About This Stock
Read
Read
Watch
Read
Galapagos Sinks After FDA Issues Complete Response Letter To Partner Gilead
Article By:
The Fly
Wednesday, August 19, 2020 7:40 AM EDT
Galapagos last night announced that Gilead Sciences received a Complete Response Letter from the FDA for the New Drug Application for filgotinib, an investigational treatment for moderately to severely active rheumatoid arthritis.
Week In Review: Taimei Raises $212 Million For AI Life Science Support Software
Article By:
ChinaBio® Today
Sunday, October 20, 2019 4:00 AM EDT
Deals, financings, trials and approvals in the China bio markets over the past week.
My Favorite Strategies And Stocks For The Long Run In Belgium
Video By:
Option Generator
Saturday, March 16, 2019 9:30 PM EDT
In this video, I zero in on my favorite strategies and what Belgian stocks you should own for the long run.
E ADRs Best & Worst Report - July 11, 2016
Article By:
E.B. Capital Markets
Monday, July 11, 2016 9:00 AM EDT
The average ADR is trading -23.76% below its 52 week high, 2.83% above its 200 dma, has 3.72 days to cover held short, and is expected to grow its EPS by 17.58% next year.
In this article: AXS, AZN, BCE, BMO, CEO, CNQ, ECA, GSK, HMY, KEP, KT, NVO, RDY, RY, SHI, SID, SNP, STO, TU, YZC, SUBCY, GOLD, GSOL, AMRN, DRD, GLPG